DOAC Prescribing in Patients with Non-Valvular AF and for the Treatment and Prevention of VTE
** This bulletin supersedes MUE 05 **
The FAQ includes:
- Questions relating to indications/appropriateness of DOACs
- Questions relating to choice of DOAC & dose
- Questions relating to DOAC initiation
- Further information and advice
- Decision making algorithms
April 2023 update:
This bulletin is in the process of being replaced with a Medicines Update blog series on DOACs. Blogs in the series published to date include: